KRAS Q61H drives acquired resistance to toceranib through sustained RAS–MAPK signaling in canine mast cell tumor cells

Disease and Therapeutics · Elsevier

Аннотация

Publication date: 2026 Source: Disease and Therapeutics, Volume 3 Author(s): Nobuyuki Fujiwara, Ryo Oya, Ryouichi Tsunedomi, Akira Matsuda, Koji Hayakawa, Kosuke Kobayashi, Takashi Ohama

Читать у издателя →

Похожие статьи